Monte Rosa Therapeutics Earnings beat, Revenue Inline In Q3

  • Investing.com
Monte Rosa Therapeutics Earnings beat, Revenue Inline In Q3
Credit: © Reuters.

Investing.com - Monte Rosa Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.

Monte Rosa Therapeutics announced earnings per share of $-0.58 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.60 on revenue of $0.00.

Monte Rosa Therapeutics shares are down 4.96% from the beginning of the year and are trading at $8.00 , down-from-52-week-high.

Monte Rosa Therapeutics shares gained 5.26% in intra-day trade the report.

Monte Rosa Therapeutics follows other major Healthcare sector earnings this month

Monte Rosa Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100